RaheelaAshfaqMD

PubMed

• 205 citations
  Whole Slide Imaging Versus Microscopy for Primary Diagnosis in Surgical Pathology: A Multicenter Blinded Randomized Noninferiority Study of 1992 Cases (Pivotal Study).
  Sanjay Mukhopadhyay, Michael Feldman, Esther Abels, Raheela Ashfaq, Senda Beltaifa, Nicolas G. Cacciabeve, Helen P. Cathro, Liang Cheng, Kumarasen Cooper, Glenn E. Dic...> ;The American Journal of Surgical Pathology. 2017 Sep 1
• 380 citations
  Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Grou...
  Robert L. Coleman, Mark F. Brady, Thomas J. Herzog, Paul Sabbatini, Deborah K. Armstrong, Joan L. Walker, Byoung-Gie Kim, Keiichi Fujiwara, Krishnansu S. Tewari, David...> ;The Lancet. Oncology. 2017 Jun 1
• 44 citations
  Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment
  D. Pouessel, Y. Neuzillet, Laura S. Mertens, M.S. van der Heijden, J. De Jong, Joyce Sanders, Dennis Peters, Karen Leroy, A. Manceau, Pascale Maillé, Pascale Soyeux, A...> ;Annals of Oncology. 2016 Apr 18
• 20 citations
  Somatic alterations in juvenile polyps from BMPR1A and SMAD4 mutation carriers.
  Robert H. E. Blatter, Martina Plasilova, Friedel Wenzel, Sefik T. Gokaslan, Luigi Terracciano, Raheela Ashfaq, Karl Heinimann> ;Genes, Chromosomes & Cancer. 2015 Sep 1
• Le Fibroblast Growth Factor Receptor 3 (FGFR3), cible thérapeutique pour le traitement personnalisé du cancer de la vessie : validation anatomo-pathologique du concept
  Yann Neuzillet, Laura S. Mertens, Sharokh F. Shariat, Peter J. Boström, Tuomas Mirtti, Arthur I. Sagalowsky, Raheela Ashfaq, Annegien Broeks, M.S. van der Heijden, Den...> ;Progres En Urologie : Journal De L'association Francaise D'urologie Et De La Societe Francaise D'urologie. 2014 Nov 1
• 5 citations
  Molecular markers of carcinogenesis for risk stratification of individuals with colorectal polyps: a case-control study.
  Samir Gupta, Han Sun, Sang Yi, Joy Storm, Guanghua Xiao, Bijal A. Balasubramanian, Song Zhang, Raheela Ashfaq, Don C. Rockey> ;Cancer Prevention Research. 2014 Oct 1
• 23 citations
  Techniques for cytologic sampling of pancreatic and bile duct lesions
  William Brugge, John DeWitt, Jason B. Klapman, Raheela Ashfaq, Vinod Shidham, David Chhieng, Richard Kwon, Zubair Baloch, Matthew Zarka, Gregg Staerkel> ;Diagnostic Cytopathology. 2014 Apr 1
• 24 citations
  Techniques for cytologic sampling of pancreatic and bile duct lesions: The Papanicolaou Society of Cytopathology Guidelines
  William R. Brugge, John M. DeWitt, Jason B. Klapman, Raheela Ashfaq, Vinod B. Shidham, David C. Chhieng, Richard S. Kwon, Zubair W. Baloch, Matthew A. Zarka, Gregg A S...> ;Cytojournal. 2014 Jan 1
• 8 citations
  Association of tumor-associated trypsin inhibitor (TATI) expression with molecular markers, pathologic features and clinical outcomes of urothelial carcinoma of the ur...
  Oliver Patschan, Shahrokh F. Shariat, Daher C. Chade, Pierre I. Karakiewicz, Raheela Ashfaq, Yair Lotan, Kristina Hotakainen, Ulf-Håkan Stenman, Anders Bjartell> ;World Journal of Urology. 2012 Dec 1
• 19 citations
  Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy.
  Thomas F. Chromecki, Eugene K. Cha, Karl Pummer, Douglas S. Scherr, Ashutosh Tewari, Maxine Sun, Harun Fajkovic, Claus G. Roehrborn, Raheela Ashfaq, Pierre I. Karakiew...> ;BJU International. 2012 Jul 1
• 9 citations
  Molecular profiling for personalized cancer care.
  Raheela Ashfaq> ;Clinical & Experimental Metastasis. 2012 Jun 8
• 23 citations
  Role of fluorescence in situ hybridization in bladder cancer surveillance of patients with negative cytology.
  Ramy F. Youssef, Bruce J. Schlomer, Richard Ho, Arthur I. Sagalowsky, Raheela Ashfaq, Yair Lotan> ;Urologic Oncology. 2012 May 1
• 20 citations
  Molecular profiling of individual tumor cells by hyperspectral microscopic imaging
  Jonathan W. Uhr, Michael L. Huebschman, Eugene P. Frenkel, Nancy Lane, Raheela Ashfaq, Huaying Liu, Dipen R. Rana, Lawrence Cheng, Alice T. Lin, Gareth A. Hughes, Xiao...> ;Translational Research. 2012 May 1
• 35 citations
  Risk Stratification of Organ Confined Bladder Cancer After Radical Cystectomy Using Cell Cycle Related Biomarkers
  Shahrokh F. Shariat, Thomas F. Chromecki, Eugene K. Cha, Pierre I. Karakiewicz, Maxine Sun, Yves Fradet, Hendrik Isbarn, Douglas S. Scherr, Patrick J. Bastian, Karl Pu...> ;The Journal of Urology. 2012 Feb 1
• 13 citations
  Tamoxifen Downregulates Ets Oncogene Family Members ETV4 and ETV5 in Benign Breast Tissue: Implications for Durable Risk Reduction
  David M. Euhus, Dawei Bu, Xian Jin Xie, Venetia R. Sarode, Raheela Ashfaq, Kelly K Hunt, Weiya Xia, Joyce O'Shaughnessy, Michael Grant, Banu Arun, William C. Dooley, A...> ;Cancer Prevention Research. 2011 Nov 1
• 99 citations
  Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study.
  Carmen Mir, Shahrokh F. Shariat, Theodorus H. van der Kwast, Raheela Ashfaq, Yair Lotan, Andrew Evans, Sean Skeldon, Sally Hanna, Rati Vajpeyi, Cynthia Kuk, Sultan Alk...> ;BJU International. 2011 Jul 1
• 65 citations
  Human epidermal growth factor receptor 2 expression status provides independent prognostic information in patients with urothelial carcinoma of the urinary bladder
  Christian Bolenz, Shahrokh F. Shariat, Pierre I. Karakiewicz, Raheela Ashfaq, Richard Ho, Arthur I. Sagalowsky, Yair Lotan> ;BJU International. 2010 Oct 1
• 20 citations
  Analysis of genetic copy number changes in cervical disease progression
  Frank Policht, Minghao Song, Svetlana Sitailo, Anna O'Hare, Raheela Ashfaq, Carolyn Y. Muller, Larry E. Morrison, King Walter, Irina A. Sokolova> ;BMC Cancer. 2010 Aug 16
• 70 citations
  Association of Angiogenesis Related Markers With Bladder Cancer Outcomes and Other Molecular Markers
  Shahrokh F. Shariat, Ramy F. Youssef, Amit Gupta, Daher C. Chade, Pierre I. Karakiewicz, Hendrik Isbarn, Claudio Jeldres, Arthur I. Sagalowsky, Raheela Ashfaq, Yair Lotan> ;The Journal of Urology. 2010 May 1
• 52 citations
  p53 expression in patients with advanced urothelial cancer of the urinary bladder
  Shahrokh F. Shariat, Christian Bolenz, Pierre I. Karakiewicz, Yves Fradet, Raheela Ashfaq, Patrick J. Bastian, Matthew E. Nielsen, Umberto Capitanio, Claudio Jeldres, ...> ;BJU International. 2010 Feb 1
• 118 citations
  Combination of Multiple Molecular Markers Can Improve Prognostication in Patients With Locally Advanced and Lymph Node Positive Bladder Cancer
  Shahrokh F. Shariat, Daher C. Chade, Pierre I. Karakiewicz, Raheela Ashfaq, Hendrik Isbarn, Yves Fradet, Patrick J. Bastian, Matthew E. Nielsen, Umberto Capitanio, Cla...> ;The Journal of Urology. 2010 Jan 1
• 53 citations
  Estrogen and progesterone hormonal receptor expression in urothelial carcinoma of the bladder.
  Christian Bolenz, Yair Lotan, Raheela Ashfaq, Shahrokh F. Shariat> ;European Urology. 2009 Dec 1
• 51 citations
  Survivin as a Prognostic Marker for Urothelial Carcinoma of the Bladder: A Multicenter External Validation Study
  Shahrokh F. Shariat, Pierre I. Karakiewicz, Guilherme Godoy, Jose Antonio Karam, Raheela Ashfaq, Yves Fradet, Hendrik Isbarn, Francesco Montorsi, Claudio Jeldres, Patr...> ;Clinical Cancer Research. 2009 Nov 15
• 57 citations
  Plasmablastic lymphomas with MYC/IgH rearrangement: report of three cases and review of the literature.
  Agata M. Bogusz, Adam C. Seegmiller, Rolando Garcia, Ping Shang, Raheela Ashfaq, Weina Chen> ;American Journal of Clinical Pathology. 2009 Oct 1
• 37 citations
  p53 Predictive Value for pT1-2 N0 Disease at Radical Cystectomy
  Shahrokh F. Shariat, Yair Lotan, Pierre I. Karakiewicz, Raheela Ashfaq, Hendrik Isbarn, Yves Fradet, Patrick J. Bastian, Matthew E. Nielsen, Umberto Capitanio, Claudio...> ;The Journal of Urology. 2009 Sep 1
• Join now to see all